Inactive Instrument

Other languages Protagenic Therapeutics, Inc. Other OTC

Equities

PTIX

US74365N1037

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15
Protagenic Therapeutics, Inc. Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial	05-01
Protagenic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-01
Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders	03-27
Protagenic Therapeutics Achieves First Clinical Safety Milestone with Its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders	02-13
Wall Street Set to Open Slightly Higher Tuesday; Annual Inflation Declines to 3.1%	12-12
Protagonist Therapeutics, Inc. Reports 2-Year Follow Up Data from Rusfertide REVIVE Study at the ASH Annual Meeting Showing Durable Efficacy and No New Safety Signals	12-12
Protagenic Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14
Protagenic Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Protagenic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23
Protagenic Therapeutics, Inc. Appoints Timothy R. Wright as a Class I Director	29/11/22
Protagenic Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Protagenic Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22
Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22
Protagenic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	07/04/22
Protagenic Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
Protagenic Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	16/08/21
Protagenic Therapeutics : Expects to Refile New Drug Application in Q4 After Implementing Change Requested by FDA	23/07/21
Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	17/05/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Protagenic Therapeutics, Inc. Other OTC

Equities

PTIX

US74365N1037

Other languages

Filters